Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells

Daunorubicin is an anticancer drug, and cholesterol is involved in cancer progression, but their relationship has not been defined. In this study, we developed a novel experimental model that utilizes daunorubicin, cholesterol, and daunorubicin plus cholesterol in the same cells (H35) to search for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Codini, Michela, Conte, Carmela, Cataldi, Samuela, Arcuri, Cataldo, Lazzarini, Andrea, Ceccarini, Maria Rachele, Patria, Federica, Floridi, Alessandro, Mecca, Carmen, Ambesi-Impiombato, Francesco Saverio, Beccari, Tommaso, Curcio, Francesco, Albi, Elisabetta
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6274808/
https://ncbi.nlm.nih.gov/pubmed/30388783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19113424
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars